[Headlines Only] [Top Stories Only]
Categories
· Health/Science
Organizations
· Copd

• Briefs: Expectations high for new Pfizer drug  

Jump to full article: Houston (TX) Chronicle, 2002-08-16

Intro:

A new drug from Pfizer awaiting approval in the United States promises to revolutionize treatment for a smoking-related lung disease and should become the latest blockbuster for Pfizer, doctors and analysts said.

The inhaled medicine, called Spiriva, promises to be the new first choice of treatment for an estimated 16 million Americans with chronic obstructive pulmonary disease, known as COPD. [This graph only]

Jump to full article »